Study genes in families affected by acute intermittent porphyria
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study looks at how genes may affect acute intermittent porphyria (AIP) in families. You may be asked to share health information and provide urine, blood, or saliva samples to help researchers understand what changes genes can make.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able and willing to sign a consent form
- You must be at least 12 years old
- You must be willing to give blood and/or saliva and urine samples, and share clinical information
- You must be part of an AIP family (either you have an AIP-causing mutation with symptoms, or you are a close relative of someone in that situation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes that may be linked to pulmonary hypertension. By providing a saliva sample and filling out a health survey from home, you can help researchers learn more about this condition.
This study follows people with diagnosed porphyria over time to learn more about the condition using past and new lab (biochemical) and genetic (DNA) test results. It may help researchers better understand how porphyrias work and support future care.
This trial tests whether a diet high in carbohydrates can help treat acute intermittent porphyria (AIP), a condition that can cause attacks of pain and other symptoms. If you have AIP, this study wants to see if eating more carbs can prevent or manage attacks.
This study is a registry (a list) of people diagnosed with acute hepatic porphyria. It helps researchers learn about the condition and track health information over time; it doesn’t test a new drug in the way treatment trials do.
This study looks at how hormones, metabolism, and body signals relate to pulmonary arterial hypertension. You may be eligible if you (or a family member) have idiopathic, inherited, or related pulmonary arterial hypertension, and you can do required blood and other testing.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
Hear when a new Acute Intermittent Porphyria (AIP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.